Organigram Global Inc.

Organigram Global Inc.

OGI · Nasdaq

Organigram Global Inc. (OGI) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Organigram Global Inc. in 2026. The next earnings report is expected on December 22, 2026.

Earnings calendar

Next earnings date

22 Dec 2026

In 123 days

EPS estimate

0.01

Revenue estimate

85.4M

Past earnings

11 Aug 2026
EPS actual
0.18 (-18.6%)
estimate 0.22
Revenue actual
74.5M (+6.8%)
estimate 69.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
12 May 2026
EPS actual
-0.01 (-11.1%)
estimate -0.01
Revenue actual
43.0M (-15.0%)
estimate 50.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
10 Feb 2026
EPS actual
0.11 (+1,626.3%)
estimate -0.01
Revenue actual
46.3M (-13.1%)
estimate 53.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
16 Dec 2025
EPS actual
-0.20 (-4,021.6%)
estimate 0.00
Revenue actual
57.5M (+9.6%)
estimate 52.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Organigram Global missed consensus estimates for EPS but beat revenue expectations in its latest earnings report, with EPS of $0.1796 falling 18.6% short of expectations and revenue of $74.49 million exceeding estimates by 6.8%. In the prior report both EPS and revenue came in below expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Sector
Healthcare
Industry
Drug manufacturers specialty generic
Country
Canada
Exchange
Nasdaq
CEO
James H. Yamanaka
Employees
1,093
IPO date
21 May 2019
ISIN
CA68617J1003
Website
organigram.ca

Frequently asked questions

When does Organigram Global Inc. (OGI) next report earnings?

Organigram Global Inc. (OGI) is scheduled to report earnings on December 22, 2026.

What was Organigram Global Inc.'s most recent earnings date?

Organigram Global Inc. (OGI) last reported earnings on August 11, 2026.

Where is Organigram Global Inc. stock listed?

Organigram Global Inc. (OGI) is listed on Nasdaq.